Regulatory

Three proposed amendments to limit military access to dietary supplements failed to make it to a floor vote in the senate last week.

Senators McCaskill and Collins sent letters to FDA and 15 retailers of dietary supplements.

Conditions include gluten-free ingredients sourcing, cross-contamination controls, and operational management.

“Not having the cGMPs apply to ingredient suppliers definitely creates a gap in supply-chain integrity, says ONHA’s CEO and Executive Director Karen Howard.

NY AG Schneiderman and IN AG Zoeller identified four "major flaws" in FDA's cGMPs for dietary supplements.

SunOpta’s manufacturing facility in Minnesota is the first to be PVP-verified for a non-GMO claim by the USDA.

Two high-profile lawsuits may become the first to judge the constitutionality of GMO and Prop 65 labeling.

Questions include how to prevent cross-contamination and how to comply with FDA’s gluten-free rules.

The senators also criticized the “inconsistent” enforcement actions of the Department of Justice under Lynch’s predecessor, Eric Holder.

Tetrahedron is now seeking broad U.S. commercialization of its unique nature-identical ingredient Ergoneine.

“I personally feel bad for all the Chinese companies that are and have been producing good products,” says USCHPA's Crowther.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

The first months of 2015 have already offered the agency several possible opportunities to comment or take regulatory action on caffeine.

Companies must have a realistic understanding of the timeframes and effort involved.

The move comes less than a week after FDA enforced against a different stimulant adulterant.

No transparency? Pivotal data in the case building against the dietary supplement industry is still under the NY AG's lock and key.

The New York Attorney General wants better quality assurance for dietary supplements. So does the supplements industry. So how does it get there?

GNC’s CEO Mike Archbold says industry “should embrace, not fear, novel testing methods.”

FDA has drawn criticism for failing to act despite being aware of the adulteration.

Attorney General Eric Schneiderman’s letter asks Congress to launch investigation on supplements.

Nutraceutical companies who pursue IP litigation are protecting the industry at large.

The Council for Responsible Nutrition says it is “disappointed” by the outcome: “We believe it’s a mistake.”

While global health bodies emphasize the importance of folic acid, could proposed policy changes in the United States take us a step backwards?

While not necessarily “new,” growth hormone releasing peptides could become an “issue,” said John Travis of NSF International.

The alliance could eventually include a centralized software platform that enables QA managers to manage multiple certifications.

Pending food manufacturing regulations mean manufacturers and suppliers must work together toward compliance.